These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34778128)
1. Soluble Interleukin-2 Receptor Level as a Marker of Hemophagocytic Lymphohistiocytosis in Children With Severe Dengue. Singh D; Raghunathan V; Dhaliwal M; Rastogi N; Chadha R; Yadav SP Front Pediatr; 2021; 9():721857. PubMed ID: 34778128 [TBL] [Abstract][Full Text] [Related]
2. Severe Dengue and Associated Hemophagocytic Lymphohistiocytosis in PICU. Bhattacharya D; Angurana SK; Nallasamy K; Iyer R; Jayashree M Indian J Pediatr; 2019 Dec; 86(12):1094-1098. PubMed ID: 31353429 [TBL] [Abstract][Full Text] [Related]
3. Hemophagocytic Lymphohistiocytosis and Pancreatic Cancer: A Rare Association. Jaan A; Khalid F; Firoze Ahmed AM; Salman A; Meghal T; Du D J Community Hosp Intern Med Perspect; 2023; 13(5):68-71. PubMed ID: 37868670 [TBL] [Abstract][Full Text] [Related]
4. Serum soluble interleukin-2 receptor (sIL-2R) is an accurate biomarker for dengue-associated hemophagocytic lymphohistiocytosis syndrome diagnosed by Hscore. Mahabala C; Koushik VK; Manjrekar PA; Balanthimogru P Infection; 2023 Apr; 51(2):433-438. PubMed ID: 35999341 [TBL] [Abstract][Full Text] [Related]
5. Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue. Kan FK; Tan CC; Von Bahr Greenwood T; Khalid KE; Supramaniam P; Hed Myrberg I; Tan LH; Henter JI Clin Infect Dis; 2020 May; 70(11):2247-2255. PubMed ID: 31188423 [TBL] [Abstract][Full Text] [Related]
6. Clinical and Laboratory Characteristics of Hemophagocytic Lymphohistiocytosis in Children With Severe Dengue During the 2019-2020 Outbreak in Southern Colombia. Restrepo Arias VC; Salgado García DM; Merchán-Galvis AM; Narváez CF Pediatr Infect Dis J; 2023 Jun; 42(6):e204-e211. PubMed ID: 36916863 [TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic Syndrome in Children With Visceral Leishmaniasis. Daher EF; Lima LL; Vieira AP; Nascimento LS; Soares DS; Abreu KL; Zuntini KL; Silva Junior GB Pediatr Infect Dis J; 2015 Dec; 34(12):1311-4. PubMed ID: 26780020 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis]. Gao WB; Shi MJ; Zhang HY; Wu CB; Zhu JH Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):921-927. PubMed ID: 34650295 [TBL] [Abstract][Full Text] [Related]
9. Severe dengue due to secondary hemophagocytic lymphohistiocytosis: A case study. Ray U; Dutta S; Mondal S; Bandyopadhyay S IDCases; 2017; 8():50-53. PubMed ID: 28409119 [TBL] [Abstract][Full Text] [Related]
10. HLH Syndrome in a Community Hospital: The Challenge of an Early Diagnosis. Wagner Y; Adam D; Pomeranz Engelberg G; Pomeranz A; Messinger YH Pediatric Health Med Ther; 2024; 15():111-120. PubMed ID: 38469429 [TBL] [Abstract][Full Text] [Related]
12. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis. Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941 [TBL] [Abstract][Full Text] [Related]
13. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis. Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323 [TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality. Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348 [TBL] [Abstract][Full Text] [Related]
15. Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis. Valade S; Azoulay E; Galicier L; Boutboul D; Zafrani L; Stepanian A; Canet E; Lemiale V; Venot M; Veyradier A; Mariotte E Medicine (Baltimore); 2015 Oct; 94(40):e1692. PubMed ID: 26448017 [TBL] [Abstract][Full Text] [Related]
16. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU. Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914 [TBL] [Abstract][Full Text] [Related]
17. Hyperferritinemia in Hemophagocytic Lymphohistiocytosis: A Single Institution Experience in Pediatric Patients. Basu S; Maji B; Barman S; Ghosh A Indian J Clin Biochem; 2018 Jan; 33(1):108-112. PubMed ID: 29371779 [TBL] [Abstract][Full Text] [Related]
18. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis]. Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis. Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of five cases of hepatitis associated aplastic anemia presenting with hemophagocytic lymphohistiocytosis at onset]. Wei A; Ma HH; Zhang LP; Wu RH; Zhang R; Wang TY Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):213-217. PubMed ID: 32135593 [No Abstract] [Full Text] [Related] [Next] [New Search]